Varicose Vein Treatment
A Contract Award Notice
by MILTON KEYNES UNIVERSITY HOSPITAL NHS FOUNDATION TRUST
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £317K
- Sector
- HEALTH
- Published
- 31 Oct 2024
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Milton Keynes
2 buyers
- Milton Keynes University Hospital NHS Trust Milton Keynes
1 supplier
- Veincentre Stoke on Trent
Description
The Vascular service currently doesn't have a treatment option for varicose vein patients. The vein centre offers this treatment to our patients who are currently sitting on our PTL. Prior to having this option our patients would remain on the PTL and became long waiters. There is a plan for thr future once the Trust offers radiofrequency ablation in the Treatment room. This outsourcing solution should align to the following:• Have the ability to align capacity with the defined volumes to acheive the clearance rate required• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes
Total Quantity or Scope
Services: The Vascular service currently doesn't currently have a treatment option for varicose vein patients. The vein centre offers this treatment to patients who are currently sitting on our PTL. Prior to having this option our patients would remain on the PTL and became long waiters.This outsourcing solution should align to the following:• Have the ability to align capacity with the defined volumes to acheive the clearance rate required• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomesThe Authority intends to award a contract to an existing provider following direct award process CThe approximate lifetime value of the contract is £316,548.00The services are intended to be provided from 01/10/2024 - 31/03/2025The existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard.
Award Detail
1 | Veincentre (Stoke on Trent)
|
Award Criteria
the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard | 100.0 |
PRICE | 100.0 |
CPV Codes
- 85100000 - Health services
Indicators
- Award on basis of price.
Legal Justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 12/11/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
Other Information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by 12/11/2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.Written representations can be sent to: Lisa.Johnston@mkuh.nhs.ukAward decision makers: Jonathan Dunk – Chief Finance OfficerFay Gordon – Chief Operating OfficerClaire McGillycuddy - ADO Surgery and Planned Care General SurgeryArosha Hettiarachchige - Operational Manager General SurgeryConflicts of interest identified: none. Key Criteria 1: Quality and InnovationThe Vascular service currently doesn't have a treatment option for varicose vein patients. … There is a plan to move away from the Vein Centre once we offer radiofrequency ablation in the Treatment room. This outsourcing solution should align to the following:• Have the ability to align capacity with the defined volumes to acheive the clearance rate required• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomesThe current insourcing provider is successfully delivering against the ciriteria.• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.• The insourcing provider will configure service delivery within confines of the contract.Key criteria 2: Value The value of the contract is £316,548 over a period of 6 months, and should deliver the following non-finanical benefits:• Reduction in backlogs• Increase access to timely care and treatment• Improved patient experienceThe current insourcing provider is successfully delivering against the criteria.• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.• The insourcing provider will configure service delivery within confines of the contract.Key criteria 3: Integration, collaboration and service sustainabilitySince the Vascular service is unable to currently offer varicose vein patients with treatment, not having the Vein Centre would lead to an increase in our long waiters. This will result in compromising patient safety, care and experience. Keeping the outsourcing service would ensure that we continue to tackle backlog of longest waiting patients for varicose vein treatment. This outsourcing solution should align to the following:• Have the ability to align capacity with the defined volumes to achieve the clearance rate required• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes.The current insourcing provider is successfully delivering against the criteria.• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.• The insourcing provider will configure service delivery within confines of the contract.Key criteria 4: Improving access, reducing health inequalities and facilitating choiceSince the Vascular service is unable to currently offer varicose vein patients with treatment, not having the Vein Centre would lead to an increase in our long waiters. This will result in compromising patient safety, care and experience. Keeping the outsourcing service would ensure that we continue to tackle backlog of longest waiting patients for varicose vein treatment. This outsourcing solution should align to the following:• Have the ability to align capacity with the defined volumes to achieve the clearance rate required.• Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomesThe current insourcing provider is successfully delivering against the criteria.• Given capacity constraints areound varicose vein treament volumes within the contract have been increased.• The insourcing provider will configure service delivery within confines of the contract.Key Criteria 5: Social ValueGiven that the treatment is currently not offered at MKUH the outsourcing provider will deliver the following benefits in relation to social value:• Reduced human suffering• Increase access to varicose vein care/ treatment.The current insourcing provider is successfully delivering against the criteria.• Given capacity constraints around varicose vein treatment volumes within the contract have been increased.• The insourcing provider will configure service delivery within confines of the contract.Basic selection criteria: The provider was selected based on the weighting of the following criteria:• Experience in delivering pathways aligned to the the treatment of varicose veins• Have the ability to align capacity with the defined volumes to acheive the clearance rate required • Have defined Governance processes that dovetail to MKUH's to ensure quality is monitored and delivered to achieve optimal patient outcomes
Reference
- FTS 035390-2024